Skip to content

ETHICON ER60TRecalls & reported problems

Ethicon Endo-Surgery, LLC · ETHICON 3D RELOAD 60MM BLACK · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10705036040828), received between Jun 29, 2026 and Jun 29, 2026 — classified as 1 malfunction.

The most frequently reported specific device problem is “Failure to Form Staple” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Form Staple1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 29, 2026Failure to Form Staple

    IT WAS REPORTED THAT DURING IN AN RPG CASE, THE STAPLE LINE REINFORCEMENT WAS USED FOR ESOPHAGEAL TRANSECTION. A STAPLE MALFORMATION AREA WAS FOUND AROUND THE MIDDLE OF THE STAPLE LINE. ACCORDING TO THE HOSPITAL, WHEN THEY WERE GOING TO REMOVE THE STAPLE MALFORMATION AREA, THE REMAINING STAPLE LINE WAS PROPERLY FORMED. THEREFORE, THERE WAS NO ISSUE, BUT THE SALES REP CONCERNS ABOUT THE MALFORMATION ISSUE. THE CARTRIDGE COLOR WAS BLACK. THERE WERE NO ADVERSE CONSEQUENCES TO THE PATIENT. NO ADDITIONAL INFORMATION PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25651848 ↗

Other Staple, implantable devices

All Staple, implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page